Physician profile
John G Ivanoff
NPI 1497725857
$5,680.24
in general payments reported to CMS, 2019-2025
33 companies · $703 in 2025
The $703 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $650 · 2020: $128 · 2021: $780 · 2022: $1,168 · 2023: $1,110 · 2024: $1,141 · 2025: $703.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,955.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,954.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $881.77 | 2019-2025 | |
| Pfizer INC. | $722.95 | 2019-2025 | |
| Abbott Laboratories | $596.12 | 2019-2024 | Mitraclip, Aveir |
| Astrazeneca Pharmaceuticals LP | $430.67 | 2019-2025 | Farxiga, Andexxa |
| Amgen INC. | $428.96 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $345.67 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $311.99 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $298.52 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $269.81 | 2022-2025 | Watchman Flx, Wolverine Coronary Cutting Balloon |
| Esperion Therapeutics, INC. | $250.16 | 2021-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $200.98 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $186.75 | 2020-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.60 | 2019-2024 | Lifevest |
| Novo Nordisk INC | $62.10 | 2022-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $60.42 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $57.85 | 2022-2024 | (Ck4) Mcot |
| Abiomed | $48.05 | 2025 | |
| Vivaquant INC, Dba Rhythm Express | $41.80 | 2024 | Rhythm Express |
| Impulse Dynamics (USA) INC. | $40.07 | 2023-2024 | Optimizer, Optimizer |
| Lexicon Pharmaceuticals, INC. | $37.69 | 2023-2024 | Inpefa |
| Atricure, INC. | $37.56 | 2022-2024 | |
| Daiichi Sankyo INC. | $29.33 | 2023 | Injectafer |
| Regeneron Healthcare Solutions, INC. | $28.47 | 2024 | Evkeeza |
| Medtronic, INC. | $25.43 | 2021 | |
| Alnylam Pharmaceuticals INC. | $21.00 | 2023 | Onpattro |
| Edwards Lifesciences Corporation | $20.57 | 2019 | |
| Medtronic Vascular, INC. | $18.93 | 2020 | |
| Amarin Pharma, INC. | $16.64 | 2021 | |
| Angiodynamics, INC. | $15.75 | 2025 | Alphavac |
| Biotronik INC. | $15.11 | 2020 | |
| Cordis US Corp. | $13.44 | 2023 | Mynxgrip |
| Irhythm Technologies, INC. | $13.10 | 2022 | |
| Teleflex LLC | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ivanoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.